Treatment of New World cutaneous leishmaniasis with miltefosine

This publication has 17 references indexed in Scilit:

• Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH3 (edelfosine) and amphotericin B
  Acta Tropica, 2001
• Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimonate for cutaneous leishmaniasis due to Leishmania viannia species.
  The American Journal of Tropical Medicine and Hygiene, 2001
• Appraisal of Various Random Amplified Polymorphic DNA-Polymerase Chain Reaction Primers for Leishamnia Identification
  The American Journal of Tropical Medicine and Hygiene, 1996
• Evaluation of a direct immunofluorescent antibody (difma) test using Leishmania genus - specific monoclonal antibody in the routine diagnosis of cutaneous leishmaniasis
  Revista da Sociedade Brasileira de Medicina Tropical, 1995
• Efficacy of a Short Course (10 Days) of High-Dose Meglumine Antimonate With or Without Interferon- in Treating Cutaneous Leishmaniasis in Guatemala
  Clinical Infectious Diseases, 1994
• Topical administration of hexadecylphosphocholine in patients with cutaneous lymphomas: Results of a phase I/II study
  Journal of the American Academy of Dermatology, 1993
• The Natural History of Cutaneous Leishmaniasis in Guatemala
  The Journal of Infectious Diseases, 1992
• Placebo-Controlled Clinical Trial of Sodium Stibogluconate (Pentostam) versus Ketoconazole for Treating Cutaneous Leishmaniasis in Guatemala
  The Journal of Infectious Diseases, 1992
• Placebo-Controlled Clinical Trial of Meglumine Antimonate (Glucantime) Vs. Localized Controlled Heat in the Treatment of Cutaneous Leishmaniasis in Guatemala
  The American Journal of Tropical Medicine and Hygiene, 1990
• Identification of Leishmania Spp. by Multiple Isozyme Analysis
  The American Journal of Tropical Medicine and Hygiene, 1983